Roger joined Signant Health as Chief Executive Officer in 2020. Since that time, he has led the company during a period of significant transformation and growth, establishing Signant as a leader in evidence generation solutions.
Prior to Signant, Roger was at global CRO PPD, a part of ThermoFisher. During his time there, Roger founded and was Senior Vice President and General Manager of the Accelerated Enrollment Solutions (AES) division, which offers biopharmaceutical sponsors and contract research organizations best-in-class clinical trial site conduct and patient access solutions. In his role, he was responsible for AES’s strategic direction and financial growth as its chief executive and played a pivotal role working closely with research sites and pharmaceutical organizations to solve patient recruitment challenges by utilizing digital technology and data science. Roger has also held a number of senior management positions for Acurian, Kozmo.com and Sony Corporation.
Stay current with the latest clinical trial news and learn how Flourish Research is supporting the advancement of life-changing therapeutics.